| 1 minute

£11m boost for leading Scottish antibody development company

Edinburgh-based biotechnology company MedAnnex Ltd has received a further £1m investment from The Scottish Investment Bank (SIB), the investment arm of Scotland’s national economic development agency, Scottish Enterprise.

This adds to a recent £10m Series B investment, by Boston-based global Life Sciences investor Morningside Ventures, to close an £11m funding round for MedAnnex.

Please see here:



For further coverage, please see here:

£11 million boost for Scottish antibody development company


Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News